• Services
    • Overview
    • Autoantibody Biomarker Profiling
    • Oncology Drug Screening
    • Immunoprofiling
    • Vaccine Development
    • Custom Protein Arrays
  • Applications
        • Disease Area
          • Autoimmune Disease
          • Immuno-oncology
          • Neurological Disease
          • Infectious Disease
        • Application Area
          • Biomarker Discovery
          • Patient Stratification
          • Response & Adverse Event Prediction
          • Diagnostics & CDx Development
  • Technology
    • Overview
    • KREX Protein Folding Technology
    • ORVAR Autoantigen Discovery Platform
    • The Value of Autoantibodies
    • Bioinformatics for Autoantibodies
  • Resources
    • Videos
    • Publications
    • Product Information
    • White Papers & Case Studies
    • Protein List
    • FAQ
  • About
    • Company Overview
      • Patents
    • Meet Our Team
    • News & Events
  • Menu Menu
  • Join Our Team
  • Contact

Patents

Building on a strong IP foundation

Sengenics has robust intellectual property (IP) protection for its innovations in key application areas in multiple jurisdictions worldwide.

  • Core Technology Patents
  • Companion Diagnostics Patents
  • Sero-Diagnostics Patents

Core Technology Patents

  • Patent Number
  • Descriptions
  • View Patent

JP4377242

Methods of determining method, and a folded state to increase the protein tag, and solubility including biotinylation domain View Patent

AU2002352355

Protein arrays for allelic variants and uses thereof View Patent

CA2469403

Protein arrays for allelic variants and uses thereof View Patent

EP1456668

Protein arrays for allelic variants and uses thereof View Patent

AU2003238441

Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent

CA2474457

Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent

EP1470229

Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent

GB2361698

Modification of DNA molecules View Patent

EP1485411

Arrays of cytosolic accessory proteins immobilized on a surface and pertinent methods View Patent

US8999897

Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state View Patent

JP4730804

Generating protein arrays View Patent

JP4781628

Protein arrays and their use for the allelic variants View Patent

US7816098

Methods of making and using a protein array View Patent

US20180305840

Protein arrays and their use to assay the protein products of highly homologous or related DNA coding sequences View Patent

Companion Diagnostics Patents

  • Patent Number
  • Descriptions
  • View Patent

WO/2022/108522

Biomarkers for predicting immunogenicity and therapeutic responses to adalimumab in rheumatoid arthritis patients View Patent

Sero-Diagnostics Patents

  • Patent Number
  • Descriptions
  • View Patent

US20180321244A1

Method for detection and diagnosis of Oral Cancer in a sample View Patent

AU2018100578A4

Method for detection and diagnosis of Oral Cancer in a sample View Patent

WO/2020/122817

Detection of biomarkers for Non-Small Cell Lung Cancer View Patent

WO/2021/061048

Identification of health status in the elderly using immunological biomarkers View Patent

Ready to accelerate your program?

Let’s discuss your needs
  • Services
  • Applications
  • Technology
  • Resources
  • About

Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, therapeutic response prediction and development of companion diagnostics.

Copyright 2008 – 2022 Sengenics All rights reserved. Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D

Terms & Conditions | Terms of Use | Privacy Statement | Cookie Policy | Code of Conduct | Whistleblowing Policy

Design and development by RainCastle Communications.

This site uses cookies. By continuing to use this site, you accept our use of cookies. Learn more about our Privacy Statement and Cookie Policy here.

I Accept

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Accept settingsHide notification only

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Download the White Paper

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

"*" Indicates required fields

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation


Read the Review

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.